Sanders and Cummings Request Pricing Info From PTC Therapeutics for Critical Drug
WASHINGTON, March 22 – Sen. Bernie Sanders (I-Vt.) and Rep. Elijah E. Cummings (D-Md.), Ranking Member of the House Committee on Oversight and Government Reform, requested information Wednesday from PTC Therapeutics, Inc. about the price they intend to charge for the brand name version of deflazacourt, a drug used to treat a deadly genetic muscle deterioration disorder. PTC recently purchased